RapidPulse
Summary active Updated Jul 20, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
RapidPulse is a Miami, Florida-based medical device company developing a next-generation aspiration platform for treating acute ischemic stroke through mechanical thrombectomy 123. The company’s proprietary technology uses “controlled cyclic aspiration” — a pulsed approach intended to improve clot engagement and removal compared with conventional aspiration methods 12. RapidPulse was spun out of medical device incubator Syntheon 12. On 2026-07-16, the company announced an oversubscribed $48 million Series B co-led by Medtronic, TechWald Next S.p.A., and S3 Ventures, with proceeds funding completion of the TURBO clinical trial (Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions) 124.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-07-16 | Series B | $48M | Medtronic, TechWald Next, S3 Ventures | SBI Investment Company, Florida Opportunity Fund, Santé Ventures, Syntheon, Hatteras Venture Partners, Epidarex Capital 1234 |
Total raised to date: $48M+ (this Series B was oversubscribed) 14.
What Investors Say
No direct-quoted investor testimonials found in the round announcement at time of publication.
What Founders Say
No independently sourced founder testimonials with direct quotes found at time of publication.
Sources
-
“RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology,” GlobeNewswire, July 16, 2026. Accessed July 2026. https://www.globenewswire.com/news-release/2026/07/16/3328436/0/en/RapidPulse-Secures-Oversubscribed-48M-Series-B-Financing-to-Advance-Clinical-Development-of-Next-Generation-Stroke-Aspiration-Technology.html↩↩↩↩↩↩
-
“RapidPulse Secures Oversubscribed $48M Series B Financing,” BioSpace, July 16, 2026. Accessed July 2026. https://www.biospace.com/press-releases/rapidpulse-secures-oversubscribed-48m-series-b-financing-to-advance-clinical-development-of-next-generation-stroke-aspiration-technology↩↩↩↩↩
-
“Miami-based RapidPulse secures $48M Series B co-led by Medtronic to transform stroke treatment,” Refresh Miami, July 2026. Accessed July 2026. https://refreshmiami.com/news/miami-based-rapidpulse-secures-48m-series-b-co-led-by-medtronic-to-transform-stroke-treatment/↩↩
-
“RapidPulse raises $48M for thrombectomy tech as Medtronic invests,” MassDevice, July 2026. Accessed July 2026. https://www.massdevice.com/rapidpulse-raises-48m-thrombectomy-tech-medtronic/↩↩↩
-
“RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology,” Epidarex Capital press release, July 16, 2026. Accessed July 2026. https://epidarex.com/rapidpulse-secures-oversubscribed-48m-series-b-financing-to-advance-clinical-development-of-next-generation-stroke-aspiration-technology/↩